Showing results (1341-1350 of 1,710) with videos related to

Sort By:
Pageof 171
Chemistry (Weinheim an Der Bergstrasse, Germany)|November 13, 2003
Structural study of the thermal and photochemical spin states in the spin crossover complex [Fe(phen)2(NCSe)2]Elizabeth J MacLean, Catherine M McGrath, Charles J O'Connor, et al.
Medicine|November 12, 2015
Early Enteral Feeding After Living Donor Liver Transplantation Prevents Infectious Complications: A Prospective Pilot StudyJong Man Kim, Jae-Won Joh, Hyun Jung Kim, et al.
Journal of Surgical Oncology|May 13, 2010
Adenoma incidence after resection of sporadic colorectal cancer with microsatellite instabilityKi Joo Kang, Dong Hyun Sinn, Sung Hyun Park, et al.
Diagnostics (Basel, Switzerland)|May 4, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural MesotheliomaBerta Mosleh, Yawen Dong, Elisabeth Lang, et al.
The Journal of Pathology|December 5, 2009
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expressionAreeg Faggad, Jan Budczies, Oleg Tchernitsa, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 12, 2020
Impact of age on atrial fibrillation recurrence following surgical ablationRobert M MacGregor, Ali J Khiabani, Nadia H Bakir, et al.
Scientific Reports|April 10, 2020
Author Correction: Nanofocusing of hard X-ray free electron laser pulses using diamond based Fresnel zone platesC David, S Gorelick, S Rutishauser, et al.
Molecular Therapy. Methods & Clinical Development|September 30, 2020
Methods Matter: Standard Production Platforms for Recombinant AAV Produce Chemically and Functionally Distinct VectorsNeil G Rumachik, Stacy A Malaker, Nicole Poweleit, et al.
Breast Care (Basel, Switzerland)|April 26, 2019
Mismatch Repair Deficiency Drives Durable Complete Remission by Targeting Programmed Death Receptor 1 in a Metastatic Luminal Breast Cancer PatientCarlo Fremd, Mario Hlevnjak, Marc Zapatka, et al.
Scandinavian Journal of Gastroenterology|April 4, 2018
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, et al.
Pageof 171